Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in CGC — Canopy Growth Corp

CIK 1423053 MIAMI, FL
Back to CGC Full portfolio

Position in CGC

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$27,306
-$1,046,038 QoQ
Shares Held
28,744
-97.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 212 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGC Over Time

Shares Held

Position Value (USD)

Derivatives in CGC

reported options exposure · as of Jun 30, 2026
CallValue
$1,191,775
CallShares
1,254,500
PutValue
$478,040
PutShares
503,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,121,114 across 64 Drug Manufacturers - Specialty & Generic names. CGC ranks #60 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in CGC

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $478,040 503,200
2026-06-30 $27,306 28,744
2026-06-30 $1,191,775 1,254,500
2026-03-31 $1,073,344 1,131,028
2026-03-31 $1,377,568 1,451,600
2026-03-31 $621,310 654,700
2025-12-31 $1,406,326 1,233,620
2025-12-31 $3,585,060 3,144,790
2025-12-31 $2,315,702 2,031,319
2025-09-30 $5,318,832 3,643,036
2025-09-30 $2,615,560 1,791,480
2025-09-30 $1,203,113 824,050
2025-06-30 $755,924 619,610
2025-06-30 $1,164,878 954,819
2025-06-30 $1,308,572 1,072,600
2025-03-31 $579,779 637,120
2025-03-31 $751,532 825,860
2024-12-31 $2,846,120 1,038,730
2024-12-31 $437,112 159,530
2024-12-31 $2,104,758 768,160
2024-09-30 $984,836 204,323
2024-09-30 $10,678,131 2,215,380
2024-09-30 $4,215,090 874,500
2024-06-30 $9,837,604 1,525,210
2024-06-30 $965,887 149,750
2024-06-30 $8,818,246 1,367,170
2024-03-31 $11,064,695 1,282,120
2024-03-31 $3,339 387
2024-03-31 $6,489,242 751,940
2023-12-31 $1,274,076 249,330
2023-12-31 $6,980 1,366
2023-12-31 $484,836 94,880
2023-09-30 $1,388,885 1,773,800
2023-09-30 $12,371 15,800
2023-09-30 $999,186 1,276,100
2023-06-30 $467,695 1,205,400
2023-06-30 $697,740 1,798,300
2023-03-31 $2,237,550 1,278,600
2023-03-31 $1,973,650 1,127,800
2022-12-31 $815,697 353,116
2022-12-31 $2,887,269 1,249,900
2022-12-31 $3,848,922 1,666,200
2022-09-30 $4,280,094 1,567,800
2022-09-30 $407,004 149,086
2022-09-30 $4,373,733 1,602,100
2022-06-30 $1,278,906 448,739
2022-06-30 $4,085,760 1,433,600
2022-06-30 $6,214,140 2,180,400
2022-03-31 $4,511,616 595,200
2022-03-31 $16,791,216 2,215,200

Report a Problem

Category
Description
Email (optional, for follow-up)